SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort.

SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort.

Identifying the potential for SARS-CoV-2 reinfection is crucial for understanding possible long-term epidemic dynamics. We analysed longitudinal PCR and serological testing data from a prospective cohort of 4,411 United States employees in 4 states between April 2020 and February 2021. We conducted...

Full description

Saved in:
Bibliographic Details
Main Authors: Emilie Finch, Rachel Lowe, Stephanie Fischinger, Michael de St Aubin, Sameed M Siddiqui, Diana Dayal, Michael A Loesche, Justin Rhee, Samuel Beger, Yiyuan Hu, Matthew J Gluck, Benjamin Mormann, Mohammad A Hasdianda, Elon R Musk, Galit Alter, Anil S Menon, Eric J Nilles, Adam J Kucharski, CMMID COVID-19 working group and the SpaceX COVID-19 Cohort Collaborative
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-02-01
Series:PLoS Biology
Online Access:https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3001531&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3001531&type=printable

Similar Items